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Abstract
Prosthetic wear debris-induced peri-implant osteolysis is a
major cause of aseptic loosening after total joint replacement. In
this condition, wear particles released from the implant
components induce a granulomatous inflammatory reaction at
the interface between implant and adjacent bone, leading to
progressive bone resorption and loss of fixation. The present
study was undertaken to characterize definitively the phenotype
of osteoclast-like cells associated with regions of peri-implant
focal bone resorption and to compare the phenotypic features
of these cells with those of mononucleated and multinucleated
cells associated with polyethylene wear particles. Peri-implant
tissues were obtained from patients undergoing hip revision
surgery for aseptic loosening after total joint replacement. Cells
were examined for the expression of several markers associated
with the osteoclast phenotype using immunohistochemistry,
histochemistry, and/or in situ hybridization. CD68 protein, a
marker expressed by multiple macrophage lineage cell types,
was detected in mononucleated and multinucleated cells
associated with polyethylene particles and the bone surface.
Cathepsin K and tartrate-resistant acid phosphatase were
expressed highly in both mononucleated and multinucleated
cells associated with the bone surface. Levels of expression
were much lower in cells associated with polyethylene particles.
High levels of β3 integrin protein were detected in cells in
contact with bone. Multinucleated cells associated with
polyethylene particles exhibited faint positive staining. Calcitonin
receptor mRNA expression was detected solely in
multinucleated cells present in resorption lacunae on the bone
surface and was absent in cells associated with polyethylene
particles. Our findings provide further evidence that cells
expressing the full repertoire of osteoclast phenotypic markers
are involved in the pathogenesis of peri-implant osteolysis after
total joint replacement. They also demonstrate that foreign body
giant cells, although believed to be phenotypically and
functionally distinct from osteoclasts, express many osteoclast-
associated genes and gene products. However, the levels and
patterns of expression of these genes in the two cell types differ.
We speculate that, in addition to the role of cytokines and
growth factors, the substrate with which these cells interact
plays a critical role in their differential phenotypic and functional
properties.
Introduction
Inflammatory processes that target the skeleton are frequently
accompanied by a localized disturbance in bone remodeling.
The present study investigates a prototypical inflammatory dis-
order, namely peri-implant osteolysis after total joint replace-
ment (TJR), in which localized bone resorption ultimately leads
to loss of prosthetic fixation and implant loosening. In this con-
dition, wear particles generated from orthopaedic implant
components or from bone cement used for fixation gain
access to the peri-implant bone interface, where they induce a
granulomatous inflammatory reaction characterized by the
presence of fibroblast-like cells, macrophages, and multinucle-
ated foreign body giant cells. In localized areas where the
inflammatory tissue is in contact with the bone surface there
are focal regions containing mononucleated and multinucle-
ated 'osteoclast-like' cells residing within resorption lacunae.
These osteoclast-like cells have been implicated in the patho-
genesis of the bone resorption associated with peri-implant
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osteolysis. Takagi and coworkers [1] demonstrated high-turn-
over peri-prosthetic bone remodeling and immature bone for-
mation around loosened total hip replacement implants,
indicating that the key role for the peri-implant osteoclast is in
peri-implant bone resorption.
The macrophages, multinucleated foreign body giant cells,
and osteoclasts that are present within the peri-implant tissues
are derived from a common hematopoietic lineage, and a vari-
ety of phenotypic markers have been utilized to distinguish
these cells from each other. Included among these are a vari-
ety of genes and gene products that impart to the osteoclast
the unique capacity to recognize and bind to the bone surface
in order to resorb a mineralized bone matrix. The attachment
and activation of the osteoclast has been shown to involve
several different integrins, including the vitronectin receptor
αvβ3 [2,3]. Expression of this integrin has served as a useful
marker to identify osteoclasts and to distinguish them from
their colony forming unit-macrophage (CFU-M) precursors
that do not express the β3 gene [4]. Additional gene products
that are essential for creating an acidic environment for mineral
dissolution and resorption of the organic matrix of bone are
induced during osteoclast differentiation. Cathepsin K and tar-
trate-resistant acid phosphatase (TRAP) are among the
enzymes that are expressed in these cells and contribute to
the resorption of the extracellular matrix component of bone
[5-7].
Although the expressions of these genes have served as use-
ful markers to identify osteoclasts, several studies have dem-
onstrated that their expression is not restricted to osteoclasts.
For example, under certain conditions, TRAP activity and
cathepsin K have been detected in cells that are not involved
directly in bone resorption [8-10]. In our own studies involving
analysis of synovial tissues from patients with rheumatoid
arthritis [11] we observed that, in addition to cathepsin K and
TRAP expression, osteoclast-like cells in resorption lacunae at
the bone-pannus interface express the calcitonin receptor
(CTR). In in vitro mouse and human osteoclast differentiation
models, expression of the CTR occurs during the terminal
stage of osteoclast differentiation, and activation coincides
with the competence of the cell to resorb bone. The expres-
sion of this gene and gene product can thus be used to help
discriminate mature osteoclasts from macrophages or macro-
phage polykaryons, and to identify osteoclasts that are actively
involved in bone resorption.
In the present study we utilized immunohistochemical, histo-
chemical and in situ hybridization techniques to analyze the
phenotype of cells in human peri-implant tissues from patients
with aseptic implant loosening after TJR. Special attention was
focused on the differential phenotype of cells associated with
polyethylene wear particles or the bone surface. Our results
provide further evidence that cells expressing the full reper-
toire of osteoclast phenotypic markers are involved in the
pathogenesis of peri-implant osteolysis after TJR. They also
demonstrate that foreign body giant cells, although believed to
be phenotypically and functionally distinct from osteoclasts,
express many osteoclast-associated genes and gene prod-
ucts. However, the levels and pattern of expression of these
genes in the two cell types differs. Osteoclasts and foreign
body giant cells are derived from a common hematopoietic
precursor, and we speculate that, in addition to the role of
cytokines and growth factors, the substrate with which these
cells interacts plays a critical role in their differential pheno-
typic and functional properties.
Materials and methods
Human tissue collection and preparation
Human peri-implant tissues associated with foreign body reac-
tions to orthopedic implant wear debris were obtained from 12
patients. These patients had a clinical history of osteoarthritis
and were undergoing revision surgery for aseptic loosening of
prosthetic components after total hip replacement. The
patients' ages ranged between 45 and 87 years; nine were
female and three were male. Patients with a prior history of
inflammatory arthritis were excluded from the analyses. The
study protocol was approved by the New England Baptist
Hospital and the Beth Israel Deaconess Medical Center Insti-
tutional Review Boards, and informed consent was obtained
from all patients before surgery.
Figure 1
Preoperative radiograph from a study patient before revision hip arthro- plasty for aseptic loosening Preoperative radiograph from a study patient before revision hip arthro-
plasty for aseptic loosening. Arrows denote the area of extensive peri-
implant osteolysis along the femoral shaft.Available online http://arthritis-research.com/content/8/3/R70
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Specimens of soft tissue and bone were collected from
regions of bone resorption during joint revision surgery. The
specimens were fixed in freshly prepared 4% paraformade-
hyde, followed by demineralization with 14% EDTA in phos-
phate-buffered saline (PBS). The specimens were processed
and embedded in paraffin and 5 µm sections were prepared
for histological, histochemical, and immunohistochemical anal-
yses.
Reagents for immunohistochemical detection and 
probes for in situ hybridisation
Antibodies included a rabbit polyclonal antibody to human
CD68 (sc-9139; Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA), which identifies macrophages and osteoclasts, and
a goat polyclonal antibody to human β3 integrin (sc-6627;
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). A rab-
bit polyclonal antibody to human cathepsin K was kindly pro-
vided by Dr D Bromme. The ABC avidin-biotin-peroxidase
complex kits were purchased from Vector Laboratories (Burl-
ingame, CA USA). RNA antisense probes for cathepsin K,
TRAP, and CTR were prepared as previously reported [11,12]
and sense probes were used as negative controls.
Histochemistry
Histochemical staining for TRAP activity was done as previ-
ously reported [11]. The sections were incubated with the rea-
gents at 37°C for 10–20 minutes followed by counterstaining
with hematoxylin.
Immunohistochemistry
For immunohistochemistry, sections were dewaxed and sub-
jected to antigen retrieval in 10 mmol/l EDTA (pH 7.5) and
microwaved at 93°C for 7 minutes. Immunohistochemical
staining was performed as previously reported [13]. Briefly,
after rinsing with PBS the sections were pretreated with 3.0%
hydrogen peroxide at room temperature for 20 minutes to
inhibit endogenous peroxidase. Sections were then treated
with blocking solution containing 1.5% (vol/vol) normal goat or
rabbit serum (based on the animal secondary antibodies) and
10% fetal calf serum for 60 minutes at room temperature.
Excess serum was gently blotted off and the sections were
incubated with primary antibodies diluted in PBS containing
1.5% bovine serum albumin (CD68 1:100, β3 integrin 1:200
and cathepsin K 1:8000) at 4°C overnight or for 2 hours at
room temperature. After thorough rinsing, the sections were
incubated with an affinity-purified, biotinylated secondary anti-
body (1:200 in PBS), followed by incubation with avidin-biotin-
peroxidase complex for 30 minutes each, at room temperature.
After rinsing, the sections were developed with diaminobenzi-
dine tetrahydrochloride substrate (Vector Laboratoriess, Burl-
ingame, CA USA) and counterstained with hematoxylin, and
then sealed with Permount (Fisher Scientific Company, Fair
Lawn, NJ, USA). Sections were observed and photographed
using a Nikon transmitted light microscope. Routine control
experiments for checking specificity of the primary and sec-
ondary antibodies were performed by replacing the specific
antibody with normal IgG or PBS.
In situ hybridisation
For in situ hybridization, RNA sense and antisense probes
were transcribed and labeled with 35S dATP (New Life Sci-
ence, Boston, MA, USA) using an in vitro transcription kit, as
previously described [11,12]. The hybridization solution con-
tained the following: 50% (vol/vol) de-ionized formamide; 10%
(weight/vol) dextran sulphate; 1 × Denhardt's solution; 0.02%
(weight/vol) of each of bovine serum albumin, Ficoll and poly-
vinylpyrrolidone, 4 × SSC (sodium chloride and sodium cit-
rate), denatured salmon sperm DNA (0.5 µg/µl) and yeast
tRNA (0.25 µg/µl); 1% (weight/vol) sodium N-lauroylsarcosi-
nate; and 20,000 counts per minute (cpm) 35S-labeled oligo-
nucleotide probe per microliter. Dithiothreitol was directly
added at 0.1 mol/l to the hybridization solution before use.
The hybridization procedures used were similar to those used
previously [11,12]. Briefly, sections were dewaxed and post-
fixed in 4% (weight/vol) freshly prepared paraformadehyde in
PBS, acetylated with 0.25% (vol/vol) acetic anhydride in 0.1
mol/l triethanolamine buffer, and then dehydrated in increasing
concentrations of ethanol. Each section was hybridized with
105 cpm labeled sense or antisense RNA probes in a humid
Figure 2
Sections of human peri-implant tissues stained by hematoxylin and eosin Sections of human peri-implant tissues stained by hematoxylin and eosin. (a) Multinucleated cell associated with a polyethylene (PE) wear particle. 
(b) Multinucleated cells line the bone surface at site of bone resorption.Arthritis Research & Therapy    Vol 8 No 3    Shen et al.
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chamber overnight at 52°C. After hybridization, the sections
were washed in 2 × SSC at 50°C and then dehydrated in an
ascending series of ethanol solutions containing 0.3 mol/l
ammonium acetate. After dipping in Kodak photographic
emulsion, the sections were stored with desiccant at 4°C for
12–20 weeks. The photoemulsion was developed and fixed,
and sections were counterstained with hematoxylin and
mounted in Kaiser's medium (glycerol/gelatin; Merck, Darm-
stadt, Germany). The slides were examined and photographed
with both bright-field and dark-field illumination.
Results
Figure 1 is a representative radiograph from one of the study
patients taken before revision hip arthroplasty. The radiograph
demonstrates extensive peri-implant osteolysis along the fem-
oral shaft. Tissues from this patient and the other individuals
involved in the study were retrieved from the regions of peri-
implant osteolysis and assessed for expression of macro-
phage and osteoclast cell markers.
As expected, a chronic granulomatous inflammatory reaction
consisting of histiocytes, fibroblasts, and multinucleated for-
eign body giant cells was present in all specimens. Large num-
bers of polyethylene particles of varying size (identified by
strong birefringence under polarized light microscopy) were
distributed throughout the tissues. Many of the larger polyeth-
ylene particles were associated with multinucleated foreign
body giant cells (Figure 2a). Examination of the interface
between the bone and adjacent peri-implant membrane
revealed focal regions exhibiting resorption lacunae containing
mononucleated and multinucleated osteoclast-like cells (Fig-
ure 2b).
Previous studies have shown that CD68 is expressed by mul-
tiple cell types derived from the CFU-M lineage, including tis-
sue macrophages and osteoclasts [14]. Positive CD68
staining was detected in large numbers of mononucleated and
multinucleated cells throughout the membranes. Figure 3a, b
shows representative images of the immunohistochemical
staining pattern of CD68 seen in the peri-implant tissues.
Mononuclear and multinuclear cells present on bone surfaces
were strongly positive for CD68. Cells exhibiting a more
fibroblastic morphology were CD68 negative. Similar positive
staining was detected in mononuclear and multinuclear cells
associated with polyethylene particles (Figure 3c, d).
In situ hybridization and immunohistochemical techniques
were used to examine cells for the expression of cathepsin K
or TRAP mRNA and protein. These gene products have been
used to distinguish osteoclasts from macrophages and other
CFU-M lineage cells. As shown in Figure 4a, b, multinucleated
cells associated with the bone surface exhibit high levels of
Figure 3
CD68 detection in sections of human peri-implant tissues using immunohistochemistry with rabbit polyclonal antibody CD68 detection in sections of human peri-implant tissues using immunohistochemistry with rabbit polyclonal antibody. (a, b) CD68 is detected in 
the multinuclear and mononuclear cells located in the soft tissues and multinuclear cells on the bone surface. (c, d) CD68 is also detected in multi-
nuclear and mononuclear cells associated with polyethylene (PE) particles.Available online http://arthritis-research.com/content/8/3/R70
Page 5 of 10
(page number not for citation purposes)
expression of cathepsin K mRNA. Surprisingly, mononucle-
ated and multinucleated cells associated with polyethylene
particles expressing cathepsin K mRNA were detected in all of
the tissues examined, although the mRNA levels were much
lower in cells associated with polyethylene than in cells on the
bone surfaces (Figure 4c, d). Immunohistochemical staining
with an antibody to cathepsin K revealed a similar pattern of
cathepsin K protein expression, with differential positive stain-
ing between cells associated with polyethylene (Figure 4g, h)
and those on the bone (Figure 4e, f). Examination of peri-
implant tissues for TRAP mRNA expression revealed a pattern
similar to that of cathepsin K. TRAP mRNA was detected in
mononuclear and multinuclear cells associated with both the
bone surface (Figure 5a, b) and the polyethylene particles (Fig-
ures 5c, d), although the message levels were notably higher
in the cells located in resorption lacunae at the bone surface.
Examination of tissues for the expression of TRAP enzymatic
activity revealed similar patterns of differential TRAP activity in
cells associated with the polyethylene particles and in those
associated with bone surfaces (Figure 5e-h).
To further characterize cells associated with bone substrates
and polyethylene, tissues were examined for β3 integrin protein
and CTR mRNA expression. As shown in Figure 6a, b, β3
integrin immunohistochemical staining was detected in both
the mononuclear and multinuclear cells in resorption lacunae
on the bone surface. Figure 6c shows negative staining with
the secondary antibody alone. Very weak staining was some-
times evident in cells associated with polyethylene particles
(Figure 6d, e). In contrast, CTR expression was restricted to
multinucleated cells within resorption lacunae (Figure 7a, b). In
no instance did we identify cells expressing CTR mRNA asso-
ciated with the polyethylene particles (Figure 7c, d). These
findings suggest that expression of the CTR distinguished
osteoclast cells from tissue macrophages and foreign body
giant cells, separating it from the other osteoclast cell markers
used in this study.
Discussion
Aseptic loosening of prosthetic joint implants has emerged as
the major long-term complication after TJR. The radiographic
hallmark of prosthetic loosening is the presence of radiolucent
zones at the interface between the bone and adjacent implant
materials [15-18]. These zones of osteolysis develop as a con-
sequence of an active biologic process involving the resorp-
tion of bone at the peri-implant sites. Insights into the
mechanisms involved in this focal disorder of bone remodeling
have been provided by histopathologic examination and bio-
chemical analysis of the tissues obtained at revision surgery
from patients who have developed aseptic loosening after TJR
[17,19-23]. Charnley [24], in his studies of the natural history
of patients after total hip replacement, was the first to describe
the presence of a 'macrophage foreign body reaction' associ-
ated with fragmented methylmethacrylate cement in peri-
implant tissues from loosened prostheses. Subsequently,
studies have shown that wear particles from orthopedic pros-
thetic devices of different composition, including polyethylene
Figure 4
Detection of cathepsin K mRNA and protein in sections of human peri-implantation tissues Detection of cathepsin K mRNA and protein in sections of human peri-implantation tissues. The techniques used were in situ hybridization with a 
35S-labeled anti-sense RNA probe ((a, c) bright field and (b, d) dark field) and (e-h) immunohistochemistry with a rabbit polyclonal antibody to 
human cathepsin K. Multinuclear cells on the bone surface and some mononuclear cells in the peri-implant tissues adjacent to the bone express high 
levels of cathepsin K mRNA (panels a [bright field] and b [dark field]). Low levels of cathepsin K mRNA were detected in multinuclear cells associ-
ated with polyethylene (PE) particles (panels c [bright field] and d [dark field]). Multinuclear cells on the bone surface (panels e and f) and mononu-
clear and multinuclear cells associated with PE particles (panels g and h) stain positively for cathepsin K protein. PE particles are easily identified by 
their strong bi-refringence with polarizing light microscopy.Arthritis Research & Therapy    Vol 8 No 3    Shen et al.
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and metal, have the capacity to induce a foreign body granulo-
matous reaction [19,20,25-28].
Cells exhibiting phenotypic features of macrophages and mac-
rophage polykaryons (so-called foreign body giant cells) are
the principal cell types within the peri-implant granuloma
[17,20,21,23,27,28]. In the regions immediately adjacent to
the implant surface the cells are frequently organized into a lin-
ing layer with histologic features of synovium [20]. Analysis of
the granuloma-bone interface has revealed highly variable cel-
lular composition. In many regions the bone is lined by cells
that exhibit a fibroblastic morphology. These cells fail to
express the CD68 antigen and are not believed to be of
hematopoietic origin. The association of the fibroblastic cells
with the bone surface and the ex vivo demonstration that they
can resorb a bone matrix have led some investigators to spec-
ulate that these cells represent a connective tissue subtype
possessing a unique capacity to resorb bone [29]. In addition
to the bone-tissue interface populated by fibroblasts, Willert
and coworkers [28] described regions of the bone surface
that were lined by multinucleated cells with morphologic fea-
tures of osteoclasts residing in resorption lacunae. Based on
these observations, the conclusion was drawn that the osteo-
lytic process was mediated principally via osteoclastic mecha-
nisms.
Greenfield and coworkers [25] and other investigators [30-
32] have suggested that increased recruitment of osteoclast
precursors and their differentiation play a major role in wear
particle induced osteolysis. To identify the source of the oste-
oclasts associated with the peri-implant osteolysis, Athana-
thou's group [14,33,34] and other investigators [35] have
isolated cells from peri-implant granulomatous tissue from
patients with aseptic loosening and showed that a subset of
the mononuclear cells isolated from the tissue could be
induced to form bone resorbing osteoclasts when cultured
under appropriate conditions. These findings firmly establish
the existence of osteoclast precursors within the granuloma of
peri-implant tissue. It is presumed that this pool of cells gives
rise to the osteoclasts that are associated with the bone sur-
face and mediate the osteolytic process in vivo.
Cathepsin K and TRAP are among the enzymes that are
expressed by osteoclasts. The importance of these two gene
products in osteoclast functional activity is indicated by the
resorptive defect in osteoclast-mediated bone resorption in
mice in which either of these genes has been deleted [36,37].
In humans, inactivating mutations in the cathepsin K gene are
associated with an osteoclast resorbing defect manifest by
pycnodysostosis [38]. In the present study we detected cathe-
psin K and TRAP expression in mononuclear and multinuclear
cells associated with polyethylene particles as well as the
bone surface. These findings are consistent with the observa-
tions reported by Ren and coworkers [39], who found that pol-
yethylene particles also induced cathepsin K and TRAP
expression in an air pouch implantation model, and by Kont-
tinen and colleagues [7], who found cathepsin K to be highly
expressed in bone resorption around total hip replacement
prosthesis. Of importance, in our studies we observed that the
levels of expression of both cathepsin K and TRAP were much
higher in the cells associated with the bone surface compared
with the polyethylene particles. This was evident at the mRNA
as well as the protein or functional level. We speculate that
interaction with the bone substrate may play a critical role
inducing the higher levels of expression of these two enzymes
in cells associated with the bone surface, as discussed below.
Although expressions of the cathepsin K and TRAP genes
have served as markers of the osteoclast phenotype, under
certain conditions cathepsin K and TRAP activity have been
detected in cells that are not involved directly in bone resorp-
tion [8-10,40], indicating that their expression is not restricted
Figure 6
Detection of β3 integrin in sections of human peri-implant by immunohistochemistry using a rabbit polyclonal antibody Detection of β3 integrin in sections of human peri-implant by immunohistochemistry using a rabbit polyclonal antibody. (a, b) β3 Integrin is evident in 
the membrane of mononuclear and multinuclear cells adjacent to bone. (d, e) Weak staining is evident in cells associated with polyethylene (PE) par-
ticles. Normal IgG was used as a negative control (panel c).Available online http://arthritis-research.com/content/8/3/R70
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to osteoclasts. For example, macrophages have been shown
to express both of these enzymes [41]. In the present study we
observed that β3  integrin and CTR were preferentially
expressed in cells associated with the bone surface. A number
of studies have shown that neither the β3 integrin nor the CTR
are expressed by osteoclast precursors. The expression of
these genes increases during the late stages of osteoclast dif-
ferentiation [42], after induction of the cathepsin K and TRAP
genes. Importantly, the transcriptional activation of the β3
integrin and CTR genes coincides with the transition of the
osteoclast to an actively resorbing cell [10]. Thus, based on
these in vitro studies, the levels of expression of these genes
can be used to discriminate osteoclasts from macrophages or
macrophage polykaryons, and to identify osteoclasts that are
actively involved in bone resorption. Our results suggest that
expression of the CTR may be a more definitive marker of ter-
minal osteoclast differentiation than the β3 integrin because it
was solely confined to the bone matrix whereas β3 was very
weakly detected on some multinucleated cells associated with
wear particles. Because osteoclast cells express relatively low
levels of CTR mRNA, it is also possible, as with the β3 integrin,
that CTR could be expressed in the cells associated with the
polyethylene particles but the levels were below the limits of
detection.
Relatively few studies have rigorously compared the functional
and phenotypic features of the multinucleated foreign body
giant cells associated with wear particles and the multinucle-
ated osteoclast-like cells detected in resorption lacunae at
sites of peri-implant osteolysis. Willert and coworkers [28]
commented on the absence of wear particles in osteoclast-like
cells in resorption lacunae and speculated that they were phe-
notypically distinct from the polykaryons associated with the
implant wear particles. More recently, Athanasou and cowork-
ers [14,43] cultured mononuclear cells isolated from the peri-
implant tissues retrieved from patients with granulomatous
reactions to implant materials. They showed that both mono-
cyte/macrophages and cells expressing phenotypic features
of foreign body giant cells could produce 'resorption pits' on
bone slices. The level of resorption produced by these cells,
Figure 5
Detection of TRAP mRNA and TRAP enzymatic activity in sections of human peri-implant tissues Detection of TRAP mRNA and TRAP enzymatic activity in sections of human peri-implant tissues. The techniques used were in situ hybridization with 
a 35S-labeled antisense RNA probe ((a, c) bright field and (b, d) and dark field) and (e-h) histochemistry. TRAP mRNA expression is detected in 
mononuclear (arrows) and multinuclear cells (arrowheads) on the bone surface adjacent to the peri-implant granuloma (panels a and b). Cells asso-
ciated with polyethylene (PE) particles also express TRAP mRNA (panels c and d). The enzymatic activity is evident as purple staining seen in similar 
cells (panels e-h). TRAP, tartrate-resistant acid phosphatase.Arthritis Research & Therapy    Vol 8 No 3    Shen et al.
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however, was considerably less than that observed with
authentic osteoclasts. This suggests that the cells associated
with wear particles, despite being multinuclear, are function-
ally distinct from osteoclasts. These observations support the
work of others who have found that macrophages or macro-
phage polykaryons have a limited capacity to resorb a mineral-
ized bone matrix [26,27,44].
Further evidence indicating the differential phenotype of for-
eign body giant cells and osteoclast cells is provided by our
previous studies [45,46] in which we implanted particles of
polyethylene or polymethylmethacrylate into soft tissues of rats
and analyzed the phenotypic features of the elicited cells. We
observed that the particulate polymeric materials failed to
induce cells with the full phenotypic and functional properties
of osteoclasts. In these studies we also implanted mineralized
bone particles of size comparable to that of the polyethylene
and polymethylmethacrylate particles. The bone, similar to the
polymeric materials, induced a granulomatous inflammatory
reaction. However, in contrast to the polymeric material, the
bone particles induced multiunucleated cells expressing
TRAP activity as well as CTR. Most importantly, these cells
were able to resorb the bone matrix, thus establishing their
authenticity as osteoclast cells. These observations, and the
findings of the present study using human peri-implant tissues,
indicate that binding of cells to polyethylene wear particles or
bone results in differential phenotypic expression. Based on
these findings we speculate that binding and interaction of
cells with the different substrates play important roles in regu-
lating their differential phenotypic and functional activity.
In the present study we noted the presence of abundant
CD68 positive mononucleated and multinucleated cells asso-
ciated with the polyethylene particles. Cells within resorption
lacunae at the bone surface also expressed this antigen. Other
studies have shown that osteoclasts, as well as CFU-M line-
age macrophages, express CD68, and we speculate that the
CD68-positive mononuclear cells within the granuloma repre-
sent the precursors for the osteoclast-like cells involved in the
resorptive process at the bone surface. This conclusion is sup-
ported by recent studies conducted by Sabokbar and cowork-
ers [14], who demonstrated that macrophages isolated
directly from peri-implant tissues surrounding loosened
implants exhibited limited capacity to resorb bone. However,
under appropriate culture conditions they could be induced ex
vivo to differentiate into multinucleated cells with the full func-
tional and cytochemical characteristics of osteoclasts. These
findings received support from a study conducted by Haynes
and coworkers [35].
Conclusion
Our results provide further evidence implicating osteoclasts in
the pathogenesis of the peri-implant osteolysis associated
with prosthetic implant wear debris. The findings of TRAP and
cathepsin K expression in macrophages and foreign body
giant cells associated with wear particles expression confirms
our previous observations, as well as the findings of others,
that these two enzymes are not definitive markers of the oste-
oclast phenotype [8-10,41]. β3 Integrin and CTR are associ-
ated with later stage cells of osteoclast differentiation, and
their levels of expression were much high in cells in contact
with bone as opposed to wear particles. The expression of the
CTR appears to discriminate osteoclasts from foreign body
giant cells and other CFU-M lineage cells because it is
expressed solely by cells on the bone. The findings supporting
a role for osteoclasts in the pathogenesis of peri-implant oste-
olysis have important clinical implications and suggest that tar-
geting osteoclasts, as well as the pathways that regulate
osteoclast differentiation and activation, represents a rational
therapeutic approach to preventing this major clinical compli-
cation after TJR.
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